Fospropofol Intravenous and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Fospropofol Intravenous and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fospropofol
Brand name:
Synonyms: Fospropofol (Intravenous)
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fospropofol Intravenous-Insulin degludec Subcutaneous
- Fospropofol Intravenous-Insulin detemir
- Fospropofol Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Fospropofol Intravenous-Insulin Detemir (Vials)
- Fospropofol Intravenous-Insulin detemir Subcutaneous
- Fospropofol Intravenous-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Fosrenol
- Insulin degludec and liraglutide Subcutaneous-Fosrenol (Lanthanum Chewable Tablets)
- Insulin degludec and liraglutide Subcutaneous-Fosrenol (Lanthanum Powder)
- Insulin degludec and liraglutide Subcutaneous-Fostamatinib
- Insulin degludec and liraglutide Subcutaneous-Fostamatinib disodium
- Insulin degludec and liraglutide Subcutaneous-Fosteum